MALFACINI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 3.586
AS - Asia 1.256
EU - Europa 1.165
SA - Sud America 219
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 6.251
Nazione #
US - Stati Uniti d'America 3.505
SG - Singapore 457
CN - Cina 386
IT - Italia 272
DE - Germania 227
BR - Brasile 188
PL - Polonia 165
FI - Finlandia 118
VN - Vietnam 115
HK - Hong Kong 112
GB - Regno Unito 100
UA - Ucraina 93
TR - Turchia 82
CA - Canada 48
SE - Svezia 46
RU - Federazione Russa 42
MX - Messico 27
ID - Indonesia 24
FR - Francia 23
NL - Olanda 22
JP - Giappone 19
BE - Belgio 16
IN - India 14
AR - Argentina 13
BD - Bangladesh 13
ZA - Sudafrica 9
ES - Italia 8
LT - Lituania 7
EC - Ecuador 6
IE - Irlanda 6
PK - Pakistan 6
AT - Austria 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
NP - Nepal 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
KR - Corea 3
PE - Perù 3
UZ - Uzbekistan 3
AU - Australia 2
BB - Barbados 2
BO - Bolivia 2
CH - Svizzera 2
IR - Iran 2
KW - Kuwait 2
NG - Nigeria 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AO - Angola 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.251
Città #
Dallas 809
Ashburn 379
Fairfield 264
Singapore 248
Woodbridge 232
Ann Arbor 192
Warsaw 163
Houston 150
Beijing 147
Chandler 142
Seattle 135
Munich 127
Santa Clara 126
Wilmington 119
Jacksonville 113
Hong Kong 108
Ferrara 95
Cambridge 92
Helsinki 75
New York 63
Los Angeles 59
Izmir 43
Nanjing 40
Ho Chi Minh City 36
Dong Ket 34
Milan 30
Princeton 28
Shanghai 26
Boardman 22
São Paulo 21
Dearborn 20
Bologna 19
Jakarta 18
Tokyo 18
Brussels 16
Mexico City 16
Fuzhou 15
Chicago 14
Mcallen 14
Toronto 14
Brooklyn 13
Montréal 13
Padova 13
The Dalles 13
Hanoi 12
Moscow 12
Turku 12
San Diego 11
Frankfurt am Main 10
Nanchang 10
Amsterdam 9
Hefei 9
London 9
Stockholm 9
Boston 8
Montreal 8
San Jose 8
Atlanta 7
Buffalo 7
Falls Church 7
Poplar 7
Rio de Janeiro 7
Bremen 6
Changsha 6
Chennai 6
Denver 6
Dublin 6
Jiaxing 6
Phoenix 6
Auburn Hills 5
Brasília 5
Columbus 5
Jyväskylä 5
Nuremberg 5
Shenyang 5
Tianjin 5
Addison 4
Augusta 4
Bari 4
Boydton 4
Brescia 4
Cagliari 4
Calgary 4
Da Nang 4
Dhaka 4
Guangzhou 4
Haiphong 4
Jena 4
Jinan 4
Johannesburg 4
Kunming 4
Manchester 4
Mountain View 4
Porto Alegre 4
Querétaro 4
Redwood City 4
Ankara 3
Belo Horizonte 3
Cascavel 3
Colleferro 3
Totale 4.665
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 952
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 332
Novel ligands and assays for nociceptin/orphanin FQ and classical opioid receptors 316
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 246
null 205
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 200
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 197
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 192
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 188
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 185
Pharmacological characterization of tachykinin tetrabranched derivatives 185
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 181
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 176
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 172
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 166
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 164
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 160
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 160
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 152
NOP receptor pharmacological profile – A dynamic mass redistribution study 148
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 147
Pharmacological Assays for Investigating the NOP Receptor 146
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 144
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 115
null 110
null 105
null 103
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 103
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 102
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study 98
Pharmacological characterization of naloxegol: In vitro and in vivo studies 86
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 82
In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment 81
null 78
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 50
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 49
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 36
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 19
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 14
Totale 6.345
Categoria #
all - tutte 25.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 887
Totale 26.310


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 46 18 51 29 104 66 52
2021/2022265 24 19 2 12 21 21 16 25 17 32 15 61
2022/2023317 32 31 17 42 43 40 17 34 31 3 14 13
2023/2024288 18 23 5 7 14 58 14 57 3 9 17 63
2024/20251.048 29 39 80 32 91 123 80 70 172 89 138 105
2025/20262.212 317 286 819 362 395 33 0 0 0 0 0 0
Totale 6.345